JP2020515598A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515598A5
JP2020515598A5 JP2019553439A JP2019553439A JP2020515598A5 JP 2020515598 A5 JP2020515598 A5 JP 2020515598A5 JP 2019553439 A JP2019553439 A JP 2019553439A JP 2019553439 A JP2019553439 A JP 2019553439A JP 2020515598 A5 JP2020515598 A5 JP 2020515598A5
Authority
JP
Japan
Prior art keywords
indylbin
solvent
derivative
pharmaceutically acceptable
acceptable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019553439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020515598A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/025075 external-priority patent/WO2018183631A1/en
Publication of JP2020515598A publication Critical patent/JP2020515598A/ja
Publication of JP2020515598A5 publication Critical patent/JP2020515598A5/ja
Priority to JP2023000437A priority Critical patent/JP2023040147A/ja
Pending legal-status Critical Current

Links

JP2019553439A 2017-03-29 2018-03-29 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法 Pending JP2020515598A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023000437A JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762478317P 2017-03-29 2017-03-29
US62/478,317 2017-03-29
PCT/US2018/025075 WO2018183631A1 (en) 2017-03-29 2018-03-29 Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023000437A Division JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Publications (2)

Publication Number Publication Date
JP2020515598A JP2020515598A (ja) 2020-05-28
JP2020515598A5 true JP2020515598A5 (https=) 2021-05-06

Family

ID=63676834

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019553439A Pending JP2020515598A (ja) 2017-03-29 2018-03-29 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法
JP2023000437A Withdrawn JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023000437A Withdrawn JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Country Status (7)

Country Link
US (3) US20200016087A1 (https=)
EP (1) EP3600259A4 (https=)
JP (2) JP2020515598A (https=)
CN (2) CN110709066A (https=)
AU (1) AU2018244442A1 (https=)
CA (1) CA3058407A1 (https=)
WO (1) WO2018183631A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101855423B1 (ko) * 2017-04-18 2018-05-09 주식회사 씨케이바이오텍 인디루빈 유도체를 유효성분으로 포함하는 약학 조성물
WO2020214855A1 (en) * 2019-04-17 2020-10-22 Azora Therapeutics, Inc. Topical compositions and methods for treating inflammatory skin diseases
CN114521142B (zh) * 2019-11-04 2024-07-02 Ck雷容股份有限公司 用于抑制和/或治疗神经退行性疾病和/或其临床病症的组合物和方法
CN115569196B (zh) * 2020-02-26 2024-06-18 上海科技大学 多酚类物质在抗冠状病毒中的应用
EP4329747A4 (en) * 2021-04-29 2025-03-19 Jawaharlal Nehru Centre For Advanced Scientific Research SOLUBLE ANALOGUES OF 6 BIO, AND THEIR IMPLEMENTATION
EP4412991A1 (en) 2021-10-08 2024-08-14 Azora Therapeutics, Inc. Derivatives of aryl hydrocarbon receptor agonists
CN114668744A (zh) * 2022-03-23 2022-06-28 成都大学 一种靛玉红固体脂质纳米粒及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004285522A1 (en) * 2003-10-28 2005-05-12 Centre National De La Recherche Scientifique Indirubin-type compounds, compositions, and methods for their use
WO2012012616A1 (en) * 2010-07-21 2012-01-26 Patty-Fu Giles Photoactive vitamin nanoparticles for the treatment of chronic wounds
US9193954B2 (en) * 2011-03-31 2015-11-24 University Of Rochester Methods and compositions for mesenchymal stem cell proliferation
WO2013124867A1 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules
US9707186B2 (en) * 2012-02-21 2017-07-18 Amrita Vishwa Vidyapeetham Core-shell particle formulation for delivering multiple therapeutic agents
ES2685743T3 (es) * 2012-02-29 2018-10-11 Merck Patent Gmbh Procedimiento para la fabricación de nanopartículas cargadas con principio activo
CN110123763A (zh) * 2012-06-21 2019-08-16 法斯瑞斯公司 靛玉红的奈米粒子、其衍生物以及制造和使用所述奈米粒子的方法
WO2014152451A2 (en) * 2013-03-14 2014-09-25 University Of Rochester Compositions and methods for controlled localized delivery of bone forming therapeutic agents
CN103550206B (zh) * 2013-10-23 2015-11-25 重庆市中药研究院 一种白藜芦醇靛玉红组合药物、缓释微囊剂及其应用
EP2878312A1 (en) * 2013-12-02 2015-06-03 Albert-Ludwigs-Universität Freiburg Reversible PEGylation of nanocarriers
WO2015095659A2 (en) * 2013-12-20 2015-06-25 Phosphorex, Inc. Indirubin solid dispersion composition
WO2016197262A1 (en) * 2015-06-12 2016-12-15 Bayer Pharma Aktiengesellschaft Process for the preparation of porous microparticles
JP2018523702A (ja) * 2015-08-17 2018-08-23 フォスフォレックス，インコーポレイテッド 分解性ポリマーの極小ナノ粒子

Similar Documents

Publication Publication Date Title
JP2020515598A5 (https=)
CN104136012B (zh) 制备装载有活性物质的纳米颗粒的方法
Li et al. New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment
Ravi et al. Modified pullulan nanoparticles for oral delivery of lopinavir: Formulation and pharmacokinetic evaluation
JP2022095990A (ja) 向神経活性ステロイド製剤およびｃｎｓ障害の処置方法
Diab et al. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
Nguyen et al. Cost-effective alternative to nano-encapsulation: amorphous curcumin–chitosan nanoparticle complex exhibiting high payload and supersaturation generation
WO2014108076A1 (zh) 难溶性药物凝胶组合物及其制备方法
Sotoudegan et al. Nimodipine-loaded Pluronic® block copolymer micelles: preparation, characterization, in-vitro and in-vivo studies
US20240408050A1 (en) Dihydromyricetin spray-dried dispersion formulations and methods for forming them
Moghaddam et al. Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin
WO2006038552A1 (ja) 微粒子含有組成物およびその製造方法
CN100518831C (zh) 固体纳米药物及其制备方法
CN102370622A (zh) 一种载药物纳米粒及其制备方法和应用
CN106943379A (zh) 一种藤黄酸白蛋白纳米粒及其制备方法
Yuan et al. pH‐driven entrapment of enrofloxacin in casein‐based nanoparticles for the enhancement of oral bioavailability
Kumar et al. In vitro physicochemical characterization and short term in vivo tolerability study of ethionamide loaded PLGA nanoparticles: potentially effective agent for multidrug resistant tuberculosis
Sikwal et al. Non-ionic self-assembling amphiphilic polyester dendrimers as new drug delivery excipients
CN106852911B (zh) 一种稳定的卡巴他赛白蛋白组合物及其制备方法
Patil et al. Solid Lipid Nanoparticles: A Review.
Gupta et al. Recent advances in the surfactant and controlled release polymer-based solid dispersion
Gómez-Gaete et al. Successful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticles
CN108379241B (zh) 胆甾醇疏水改性普鲁兰-多奈哌齐-聚山梨酯80纳米粒子及制备和应用
Bhirud et al. Advances in solid dispersion technology and its applications in the development of solid dosage forms
Sun et al. Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles